Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Sponsor: Alkermes, Inc.
Summary
The purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets
Official title: A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance-3)
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2025-05-22
Completion Date
2026-06
Last Updated
2026-02-12
Healthy Volunteers
No
Conditions
Interventions
ALKS 2680
Oral tablet containing ALKS 2680 for once daily administration
Placebo
Oral placebo tablet for once daily administration
Locations (48)
Alkermes Investigator Site
Cullman, Alabama, United States
Alkermes Investigator Site
Phoenix, Arizona, United States
Alkermes Investigator Site
Little Rock, Arkansas, United States
Alkermes Investigator Site
Los Angeles, California, United States
Alkermes Investigator Site
Redwood City, California, United States
Alkermes Investigator Site
San Francisco, California, United States
Alkermes Investigator Site
Colorado Springs, Colorado, United States
Alkermes Investigator Site
Brandon, Florida, United States
Alkermes Investigator Site
Miami, Florida, United States
Alkermes Investigator Site
Winter Park, Florida, United States
Alkermes Investigator Site
Atlanta, Georgia, United States
Alkermes Investigator Site
Macon, Georgia, United States
Alkermes Investigator Site
Stockbridge, Georgia, United States
Alkermes Investigator Site
Peoria, Illinois, United States
Alkermes Investigator Site
Kansas City, Kansas, United States
Alkermes Investigator Site
Lansing, Michigan, United States
Alkermes Investigator Site
Lincoln, Nebraska, United States
Alkermes Investigator Site
Middletown, New Jersey, United States
Alkermes Investigator Site
Denver, North Carolina, United States
Alkermes Investigator Site
Huntersville, North Carolina, United States
Alkermes Investigator Site
Canton, Ohio, United States
Alkermes Investigator Site
Cincinnati, Ohio, United States
Alkermes Investigator Site
Cleveland, Ohio, United States
Alkermes Investigator Site
Danville, Pennsylvania, United States
Alkermes Investigator Site
Philadelphia, Pennsylvania, United States
Alkermes Investigator Site
Wyomissing, Pennsylvania, United States
Alkermes Investigator Site
Columbia, South Carolina, United States
Alkermes Investigator Site
Austin, Texas, United States
Alkermes Investigator Site
San Antonio, Texas, United States
Alkermes Investigator Site
Sugar Land, Texas, United States
Alkermes Investigator Site
Sugarland, Texas, United States
Alkermes Investigator Site
Madison, Wisconsin, United States
Alkermes Investigator Site
Sydney, New South Wales, Australia
Alkermes Investigator Site
Bedford Park, South Australia, Australia
Alkermes Investigator Site
Clayton, Victoria, Australia
Alkermes Investigator Site
Alken, Belgium
Alkermes Investigator Site
Namur, Belgium
Alkermes Investigator Site
Prague, Czechia
Alkermes Investigator Site
Bordeaux, Gironde, France
Alkermes Investigator Site
Montpellier, Herault, France
Alkermes Investigator Site
Grenoble, Isere, France
Alkermes Investigator Site
Bologna, Italy
Alkermes Investigator Site
Milan, Italy
Alkermes Investigator Site
Verona, Italy
Alkermes Investigator Site
Zwolle, Netherlands
Alkermes Investigator Site
Barcelona, Spain
Alkermes Investigator Site
Madrid, Spain
Alkermes Investigator Site
Madrid, Spain